Indication
Malignant neoplasm of ovary associated with germline BRCA mutation
Malignant neoplasm of the ovary associated with a germline *BRCA* mutation is a hereditary gynecologic cancer characterized by malignant cellular proliferation within ovarian, fallopian tube, or primary peritoneal tissues driven by inherited pathogenic variants in *BRCA1* or *BRCA2*. Read more about Malignant neoplasm of ovary associated with germline BRCA mutation
0 drugs 0 manufacturers
Drugs that treat it
Common Malignant neoplasm of ovary associated with germline BRCA mutation therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMalignant neoplasm of the ovary associated with a germline *BRCA* mutation is a hereditary gynecologic cancer characterized by malignant cellular proliferation within ovarian, fallopian tube, or primary peritoneal tissues driven by inherited pathogenic variants in *BRCA1* or *BRCA2*.
This condition predominantly affects adult females carrying constitutional alterations that compromise homologous recombination repair of DNA double-strand breaks.
Pathophysiologically, the resulting genomic instability predisposes individuals to high-grade serous histological subtypes that commonly present at advanced stages.
The underlying deficiency in DNA repair mechanisms defines the tumor biology and serves as a key biomarker for therapeutic sensitivity to platinum-based chemotherapies and poly(ADP-ribose) polymerase inhibitors.
- nih.gov
Malignant neoplasm of the ovary associated with a germline *BRCA* mutation is a hereditary gynecologic cancer characterized by malignant cellular proliferation within ovarian, fallopian tube, or primary peritoneal tissues driven by inherited pathogenic variants in *BRCA1* or *BRCA2* Pathophysiologically, the resulting genomic instability predisposes individuals to high-grade serous histological subtypes that commonly present at advanced stages
- esmo.org
Malignant neoplasm of the ovary associated with a germline *BRCA* mutation is a hereditary gynecologic cancer characterized by malignant cellular proliferation within ovarian, fallopian tube, or primary peritoneal tissues driven by inherited pathogenic variants in *BRCA1* or *BRCA2* This condition predominantly affects adult females carrying constitutional alterations that compromise homologous recombination repair of DNA double-strand breaks
- fda.gov
Malignant neoplasm of the ovary associated with a germline *BRCA* mutation is a hereditary gynecologic cancer characterized by malignant cellular proliferation within ovarian, fallopian tube, or primary peritoneal tissues driven by inherited pathogenic variants in *BRCA1* or *BRCA2*
- nih.gov
This condition predominantly affects adult females carrying constitutional alterations that compromise homologous recombination repair of DNA double-strand breaks The underlying deficiency in DNA repair mechanisms defines the tumor biology and serves as a key biomarker for therapeutic sensitivity to platinum-based chemotherapies and poly(ADP-ribose) polymerase inhibitors
- medlineplus.gov
Pathophysiologically, the resulting genomic instability predisposes individuals to high-grade serous histological subtypes that commonly present at advanced stages
- fda.gov
Pathophysiologically, the resulting genomic instability predisposes individuals to high-grade serous histological subtypes that commonly present at advanced stages
- oncokb.org
The underlying deficiency in DNA repair mechanisms defines the tumor biology and serves as a key biomarker for therapeutic sensitivity to platinum-based chemotherapies and poly(ADP-ribose) polymerase inhibitors
- peerview.com
The underlying deficiency in DNA repair mechanisms defines the tumor biology and serves as a key biomarker for therapeutic sensitivity to platinum-based chemotherapies and poly(ADP-ribose) polymerase inhibitors
Personalize your experience
Follow Malignant neoplasm of ovary associated with germline BRCA mutation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.